logo

Alexion Pharmaceuticals Inc. (ALXN)



Trade ALXN now with
  Date
  Headline
3/20/2019 7:07:42 AM Alexion And Zealand Pharma Announce Collaboration To Develop Peptide Therapies For Complement-Mediated Diseases
3/20/2019 6:36:32 AM Alexion And Affibody AB Announce Partnership To Co-develop ABY-039
2/4/2019 6:33:23 AM Alexion Pharma Q4 Net Loss $45 Mln Or $0.20/shr Vs. Net Income $30.0 Mln Or $0.13/shr Last Year
1/31/2019 6:32:24 AM Alexion And Caelum Biosciences Announce Collaboration To Develop Targeted Therapy For Light Chain Amyloidosis
1/31/2019 6:32:04 AM Caelum Signs Strategic Agreement With Alexion To Advance Development Of CAEL-101 For Light Chain Amyloidosis
1/28/2019 6:31:58 AM Alexion Pharma Says Phase 3 Study Of ULTOMIRIS Meets Its Primary Objective
11/2/2018 11:07:42 AM Alexion Closes Acquisition Of Syntimmune
10/24/2018 6:38:47 AM Alexion Q3 GAAP EPS $1.47; Non-GAAP EPS $2.02
10/24/2018 6:32:06 AM Alexion And Dicerna Announce Collaboration To Develop RNAi Therapies For Complement-Mediated Diseases
9/26/2018 6:31:43 AM Alexion To Acquire Syntimmune For A Total Value Of Up To $1.2 Bln